OnKure Therapeutics Inc. (OKUR)
NASDAQ: OKUR
· Real-Time Price · USD
2.50
-0.04 (-1.57%)
At close: Sep 26, 2025, 10:57 AM
-1.57% (1D)
Bid | 2.41 |
Market Cap | 33.89M |
Revenue (ttm) | n/a |
Net Income (ttm) | -70.2M |
EPS (ttm) | -4.35 |
PE Ratio (ttm) | -0.58 |
Forward PE | -0.74 |
Analyst | Buy |
Dividends | n/a |
Ask | 2.6 |
Volume | 12,073 |
Avg. Volume (20D) | 82,944 |
Open | 2.49 |
Previous Close | 2.54 |
Day's Range | 2.48 - 2.53 |
52-Week Range | 1.70 - 20.00 |
Beta | 0.43 |
Ex-Dividend Date | n/a |
About OKUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OKUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OKUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+20%
OnKure Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription

11 months ago · seekingalpha.com
OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And BeyondInitial OnKure Therapeutics, Inc. data from the phase 1 PIKture-01 study, using OKI-219 for the treatment of patients with PI3Ka-H1047R breast cancer and solid tumors, is expected in Q4 of 2024. OKI-2...